J Infus Nurs 2021 Feb 26. Epub 2021 Feb 26.
University of Massachusetts Amherst, Institute for Applied Life Sciences and College of Nursing, Amherst, Massachusetts (Dr Giuliano); Center for Nursing Research and Advanced Nursing Practice, Orlando Health, Orlando, Florida (Dr Penoyer and, formerly, Ms Bennett); Parkview Regional Medical Center, Fort Wayne, Indiana (Ms Mahuren). Karen K. Giuliano, PhD, MBA, RN, FAAN, is a fellow in the American Academy of Nursing and a six-sigma green belt. She holds a BSN and PhD in nursing from Boston College, a nurse practitioner degree from the University of Massachusetts, and an MBA in global management from Babson College. She completed her postdoctoral research fellowship on intravenous (IV) infusion device safety at Yale University. Dr Giuliano actively contributes to many professional organizations and works with small, medium, and large companies on medical product development and innovation. In addition, her own interdisciplinary program of research is focused in 2 main areas: nonventilator hospital-acquired pneumonia and IV infusion safety using IV smart pumps. With a clinical background in critical care and 25+ years of global experience in the development of new medical products, Dr Giuliano is passionate about improving health care through innovation. Her expertise includes human-centered design and clinical outcomes research. Daleen Penoyer, PhD, RN, CCRP, FCNS, FCCM, has more than 45 years of nursing experience and has held roles in academia, advanced practice, research, and leadership. She holds a PhD in nursing and is a certified clinical research professional, a fellow clinical nurse specialist, and a fellow in critical care medicine. Dr Penoyer currently serves as the director for the Center for Nursing Research at Orlando Health as an active nurse scientist. She has many publications in peer-reviewed journals to her credit and speaking engagements at the local, regional, and national levels. Her research interests are in critical care, intravenous therapy devices and practices, and prevention of hospital-acquired pneumonia. Rebecca S. Mahuren, BSN, RN, received her BSN from Indiana Wesleyan University, her associate's degree in applied of science in nursing from Purdue University, and associate's degree in applied science in accounting from Indiana Vocational Technical College. She has been a registered nurse at Parkview Health for nearly 30 years. Her clinical nursing experience includes perioperative, labor and delivery, medical-surgical patient populations, and staff educator for the pharmacy and nursing departments. Since 2016, Ms Mahuren has served 12 locations across 8 Parkview campuses as their medication safety integration nurse. She is a member of the multidisciplinary smart pump steering committee and medication safety team in which she provides data analysis and reviews events involving smart pump technology. She works on process improvements and the development of sustainable interventions and communicates the changes and issues impacting such technology. Ms Mahuren participated at the 2018 Institute for Safe Medication Practices Summit to revise the guidelines for smart pump use as an infusion device and interoperability subject matter expert. Melody Bennett, MN, RN, CCRN, has more than 40 years of clinical nursing experience in a variety of settings, including critical care. She received her master's in nursing from the University of Washington, Seattle. Although she has recently retired, at the time of this study, Ms Bennett was a clinical research coordinator at Orlando Regional Medical Center, where she completed the data collection for this article, as well as many other studies.
This descriptive observational study was conducted to increase understanding of medication administration practices during actual clinical use between 2 commonly used, different types of intravenous (IV) smart pumps. Compliance with manufacturer-recommended setup requirements for both primary and secondary infusions and secondary medication administration delay was compared between a head-height differential system and a cassette system. A total of 301 medication administration observations were included in this study: 102 (34%) for the linear peristaltic IV smart pump (medical-surgical: N = 51; critical care: N = 51) and 199 (66%) for the cassette pump (medical-surgical: N = 88; critical care: N = 111). Read More